Provided by Tiger Fintech (Singapore) Pte. Ltd.

SWK Holdings Corp

13.90
-0.1900-1.35%
Volume:1.79K
Turnover:24.92K
Market Cap:170.31M
PE:12.87
High:13.96
Open:13.96
Low:13.90
Close:14.09
Loading ...

Company Profile

Company Name:
SWK Holdings Corp
Exchange:
NASDAQ
Establishment Date:
1996
Employees:
24
Office Location:
5956 Sherry Lane,Suite 650,Dallas,Texas,United States
Zip Code:
75225
Fax:
972 687 7255
Introduction:
SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. This segment also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. The Pharmaceutical Development segment provides customers pharmaceutical development, formulation, and manufacturing services, as well as formulation solutions built around its proprietary oral drug delivery technologies, the Peptelligence platform. It also offers intellectual property licensing business. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas.

Directors

Name
Position
Robert K. Hatcher
Chairman
Jerry Albright
Director
Laurie L. Dotter
Director
Marcus E. Pennington
Director

Shareholders

Name
Position
Joe D. Staggs
Chief Executive Officer
Yvette Heinrichson
Chief Financial Officer